Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Phibro Animal Health Corporation Reports Third Quarter
May 11, 2015 4:45 PM EDTTEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its third quarter ended March 31, 2015.
Highlights for the March 2015 quarter (compared to the March 2014 quarter) Net sales of $187 million, an increase of 8% Adjusted EBITDA of $27.5 million, an increase of 23% Adjusted diluted EPS of $0.41COMMENTARY
Commenting on the quarter, Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer, said, "We are pleased with the development of our Animal Health and Mineral... More
Phibro Animal Health Corporation Reports Third Quarter
May 11, 2015 4:45 PM EDTTEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced its financial results for its third quarter ended March 31, 2015.
Highlights for the March 2015 quarter (compared to the March 2014 quarter) Net sales of $187 million, an increase of 8% Adjusted EBITDA of $27.5 million, an increase of 23% Adjusted diluted EPS of $0.41COMMENTARY
Commenting on the quarter, Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer, said, "We are pleased with the development of our Animal Health and Mineral... More
Phibro Animal Health Corporation Announces the Appointment of Dr. George Gunn to Its Board of Directors and Declares Quarterly Dividend
May 11, 2015 4:15 PM EDTTEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr. Gunn's appointment expands the Board to 8 directors, 5 of whom are independent directors. Dr. Gunn will also be a member of the company's Compensation Committee.
Dr. Gunn has over thirty years' experience in the animal health industry. Most recently, Dr. Gunn was the global head of Novartis AG's Animal Health... More
Phibro Animal Health Corporation Announces the Appointment of Dr. George Gunn to Its Board of Directors and Declares Quarterly Dividend
May 11, 2015 4:15 PM EDTTEANECK, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Dr. George Gunn as a Class III director of the company, effective immediately. Dr. Gunn will be an independent director. Dr. Gunn's appointment expands the Board to 8 directors, 5 of whom are independent directors. Dr. Gunn will also be a member of the company's Compensation Committee.
Dr. Gunn has over thirty years' experience in the animal health industry. Most recently, Dr. Gunn was the global head of Novartis AG's Animal Health... More
